We are live on ! Find out more
HI

HBK Investments Portfolio holdings

AUM $10.2B
1-Year Est. Return 67.73%
This Fund
S&P 500
This Quarter Est. Return
+5.46%
1 Year Est. Return
+67.73%
3 Year Est. Return
+191.66%
5 Year Est. Return
+445.61%
10 Year Est. Return
+2,601.8%
AUM
$7.66B
AUM Growth
+$586M
Cap. Flow
-$144M
Cap. Flow %
-1.87%
Top 10 Hldgs %
54.23%
Holding
265
New
82
Increased
51
Reduced
40
Closed
50

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$332M
2
AZEK
The AZEK Co
AZEK
+$265M
3
HES
Hess
HES
+$222M
4
CHX
ChampionX
CHX
+$214M
5
DNB
Dun & Bradstreet
DNB
+$192M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$578M
2
BERY
Berry Global Group, Inc.
BERY
+$401M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$379M
4
PYCR
Paycor HCM, Inc. Common Stock
PYCR
+$201M
5
FYBR
Frontier Communications
FYBR
+$187M

Sector Composition

Rank Sector Weight
1 Energy 19.03%
2 Consumer Staples 9.38%
3 Healthcare 7.73%
4 Industrials 6.65%
5 Financials 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLYVK icon
176
Liberty Live Group Series C
LLYVK
$9.76B
$242K ﹤0.01%
+2,976
New +$219K
AIRO
177
AIRO Group Holdings
AIRO
$256M
$241K ﹤0.01%
+10,000
New +$254K
RKLB icon
178
Rocket Lab Corp
RKLB
$43.7B
$225K ﹤0.01%
+6,300
New +$154K
NEE icon
179
NextEra Energy
NEE
$175B
$223K ﹤0.01%
+3,217
New +$223K
AMZN icon
180
Amazon
AMZN
$2.83T
$222K ﹤0.01%
1,011
-508
-33% -$101K
GLXY
181
Galaxy Digital Inc
GLXY
$4.44B
$219K ﹤0.01%
+10,000
New +$203K
SLDE
182
Slide Insurance Holdings
SLDE
$2.76B
$217K ﹤0.01%
+10,000
New +$215K
AACBR
183
DELISTED
Artius II Acquisition Inc Rights
AACBR
$140K ﹤0.01%
+500,000
New +$112K
LOKVW
184
DELISTED
Live Oak Acquisition Corp V Warrants
LOKVW
$140K ﹤0.01%
+200,000
New +$101K
SDHIR
185
Siddhi Acquisition Corp Right
SDHIR
$69K ﹤0.01%
+300,000
New +$66.5K
BEAGR
186
Bold Eagle Acquisition Corp Right
BEAGR
$39.3K ﹤0.01%
125,000
-375,000
-75% -$109K
WOLF icon
187
CALL
Wolfspeed
WOLF
$1.29B
$34.3K ﹤0.01%
+86,000
New +$196K
AAPL icon
188
Apple
AAPL
$4.53T
– –
-1,017
Closed -$205K
ADT icon
189
ADT
ADT
$5.42B
– –
-160,000
Closed -$1.3M
BBIO icon
190
BridgeBio Pharma
BBIO
$15.8B
– –
-15,000
Closed -$519K
BMEZ icon
191
BlackRock Health Sciences Trust II
BMEZ
$1.05B
– –
-28,266
Closed -$421K
BROS icon
192
Dutch Bros
BROS
$7.17B
– –
-200,000
Closed -$12.3M
BXSL icon
193
PUT
Blackstone Secured Lending
BXSL
$5.82B
– –
-106,400
Closed -$3.44M
BYD icon
194
PUT
Boyd Gaming
BYD
$5.89B
– –
-49,700
Closed -$3.27M
CHTR icon
195
PUT
Charter Communications
CHTR
$17.9B
– –
-1,100
Closed -$405K
COIN icon
196
CALL
Coinbase
COIN
$47.4B
– –
-15,500
Closed -$2.67M
COIN icon
197
PUT
Coinbase
COIN
$47.4B
– –
-15,500
Closed -$2.67M
DFS
198
DELISTED
Discover Financial Services
DFS
– –
-596,072
Closed -$102M
ED icon
199
Consolidated Edison
ED
$39.8B
– –
-15,000
Closed -$1.66M
EQIX icon
200
PUT
Equinix
EQIX
$104B
– –
-10,400
Closed -$8.48M
6 7
8
9 10

Similar funds

MOACM
Mutual of America Capital Management New York $10.3B AUM 43.46% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $10.3B AUM 30.79% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
CCM
Cullen Capital Management New York $10.2B AUM 27.15% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.3B AUM 3.26% 1-Year Est. Return

HBK Investments's Q2 2025 Portfolio in Review

As of Q2 2025, HBK Investments held 265 positions worth $7.66B, up 8.3% from $7.08B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

HBK Investments's Q2 2025 filing shows 82 new, 51 increased, 40 reduced and 50 closed positions. Its largest new stake was Blueprint Medicines: 3,200,924 shares worth $410M. The largest sale was Intra-Cellular Therapies Inc., an estimated $578M.

By sector, the portfolio is most concentrated in Energy at 19% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Healthcare.

  • HBK Investments's largest Q2 2025 buy was Blueprint Medicines: 3,200,924 shares worth $410M.
  • HBK Investments added most to The AZEK Co in Q2 2025, an estimated $265M increase.
  • HBK Investments's biggest Q2 2025 reduction was Kellanova, cutting an estimated $107M.
  • HBK Investments fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $578M.
  • HBK Investments's ten largest holdings make up 54% of its $7.66B portfolio in Q2 2025.
  • HBK Investments opened 82 new positions and closed 50 in Q2 2025.
  • HBK Investments's portfolio value rose 8.3% quarter-over-quarter to $7.66B.

Based on HBK Investments's 13F filing for Q2 2025, filed 13 Aug 2025.